Status and phase
Conditions
Treatments
About
An open-label, extension, Phase III study to evaluate the long-term safety and efficacy of MRA in patients with sJIA who were participated in Studies MRA011JP or MRA316JP
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion criteria (MRA011JP patients)
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
60 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal